IP Library Granted Patent US 12,606,817
Granted Patent B2
US 12,606,817 · App. 16/906,626 · Granted Apr 21, 2026

Methods of creating and screening DNA-encoded libraries

Inventor: Richard W. Wagner (Cambridge, MA)
Assignee: X-Chem, Inc.
C12N15/1065C12N15/1068C40B40/08C40B50/06C40B70/00C07H21/00C40B40/04C40B40/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,606,817
App. No.
16/906,626
Granted
Apr 21, 2026
Kind
B2
Abstract

The present invention features a number of methods for identifying one or more compounds that bind to a biological target. The methods include synthesizing a library of compounds, wherein the compounds contain a functional moiety having one or more diversity positions. The functional moiety of the compounds is operatively linked to an initiator oligonucleotide that identifies the structure of the functional moiety.

Claims (37)

1 . A library of at least 1,000,000 different complexes, wherein each complex comprises:

(a) a bifunctional linker comprising a first functional group and a second functional group;

(b) a compound comprising at least two chemical building blocks;

(c) a single-stranded initiator oligonucleotide, wherein the initiator oligonucleotide forms a hairpin structure, the hairpin structure having a single-stranded loop comprising at least one natural nucleoside or nucleoside analog; and

(d) an identifier region that encodes the compound, the identifier region comprising at least two oligonucleotide tags, the first oligonucleotide tag encoding the first chemical building block of the compound and the second oligonucleotide tag encoding the second chemical building block of the compound,

wherein the first functional group of the bifunctional linker is covalently bound to the first chemical building block of the compound;

wherein the second functional group of the bifunctional linker is covalently bound to the single-stranded initiator oligonucleotide;

wherein the first oligonucleotide tag of the identifier region is ligated to the initiator oligonucleotide;

wherein the second oligonucleotide tag of the identifier region is ligated to the complex through ligation to the first oligonucleotide tag of the identifier region; and

wherein the second functional group of the bifunctional linker is covalently bound within the initiator oligonucleotide or in the middle of the initiator oligonucleotide;

the complexes comprising different compounds.

2 . A library of complexes, wherein each complex comprises:

(a) a bifunctional linker comprising a first functional group and a second functional group;

(b) a compound comprising at least two chemical building blocks;

(c) a single-stranded initiator oligonucleotide, wherein the initiator oligonucleotide forms a hairpin structure, the hairpin structure having a single-stranded loop comprising at least one natural nucleoside or nucleoside analog; and

(d) an identifier region that encodes the compound, the identifier region comprising at least two oligonucleotide tags, the first oligonucleotide tag encoding the first chemical building block of the compound and the second oligonucleotide tag encoding the second chemical building block of the compound,

wherein the first functional group of the bifunctional linker is covalently bound to the first chemical building block of the compound;

wherein the second functional group of the bifunctional linker is covalently bound to the single-stranded initiator oligonucleotide;

wherein the first oligonucleotide tag of the identifier region is ligated to the initiator oligonucleotide;

wherein the second oligonucleotide tag of the identifier region is ligated to the complex through ligation to the first oligonucleotide tag of the identifier region; and

wherein the initiator oligonucleotide and bifunctional linker combination of the complex have an octanol: water coefficient from 1.0 to 2.5;

the complexes comprising different compounds.

3 . The library of claim 2 , wherein the library comprises at least 1,000,000 different complexes, the complexes comprising different compounds.

4 . The library of claim 1 or 2 , wherein the second functional group of the bifunctional linker of each complex is covalently bound to the single-stranded loop of the hairpin structure of the initiator oligonucleotide of that complex.

5 . The library of claim 1 or 2 , wherein the bifunctional linker of each complex comprises a chemically inert spacer of variable length.

6 . The library of claim 1 or 2 , wherein the bifunctional linker of each complex comprises one or more of a chain of ethylene glycol units, an alkane, an alkene, polyene chain, or peptide chain.

7 . The library of claim 6 , wherein the bifunctional linker of each complex comprises one or more of a chain of ethylene glycol units.

8 . The library of claim 1 or 2 , wherein the first functional group of the bifunctional linker of each complex comprises a carboxylic acid.

9 . The library of claim 1 or 2 , wherein the second functional group of the bifunctional linker of each complex comprises an amine, a thiol, an azide, or an alkyne.

10 . The library of claim 9 , wherein the second functional group of the bifunctional linker of each complex comprises an amine.

11 . The library of claim 1 or 2 , wherein the initiator oligonucleotide of each complex comprises a T or C nucleotide comprising an aliphatic chain at the C5 position.

12 . The library of claim 1 or 2 , wherein the initiator oligonucleotide of each complex comprises a primer-binding region for polymerase amplification.

13 . The library of claim 1 or 2 , wherein the initiator oligonucleotide of each complex comprises an azobenzene.

14 . The library of claim 1 or 2 , wherein the compound of each complex is a small molecule.

15 . The library of claim 1 or 2 , wherein each oligonucleotide tag of each complex is double-stranded.

16 . The library of claim 1 or 2 , wherein each oligonucleotide tag of each complex is ligated to one or two adjacent oligonucleotide tags.

17 . The library of claim 1 or 2 , wherein the hairpin structure of each complex comprises a self-complementary region of 5 to 20 base pairs in length.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2021
From: WAGNER, RICHARD W.
To: X-CHEM, INC.
Reel/Frame 056825/0677 →
SECURITY INTEREST Recorded Dec 11, 2020
From: X-CHEM, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 054619/0407 →
Continuity (4)
Continuation 15147600 · May 5, 2016
Continuation 13147910
Provisional Application 61152508 · Feb 13, 2009
Related Publication 20200385709A1 · Dec 10, 2020
References Cited (400)
US 5013830A · Ohtsuka et al. · 1991 [cited by applicant]
US 5476930A · Letsinger et al. · 1995 [cited by applicant]
US 5525734A · Gallop et al. · 1996 [cited by applicant]
US 5525735A · Gallop et al. · 1996 [cited by applicant]
US 5571677A · Gryaznov · 1996 [cited by applicant]
US 5571903A · Gryaznov · 1996 [cited by applicant]
US 5573905A · Lerner et al. · 1996 [cited by applicant]
US 5585481A · Arnold, Jr. et al. · 1996 [cited by applicant]
US 5604097A · Brenner · 1997 [cited by applicant]
US 5633360A · Bischofberger et al. · 1997 [cited by applicant]
US 5635400A · Brenner · 1997 [cited by applicant]
US 5639603A · Dower et al. · 1997 [cited by applicant]
US 5654413A · Brenner · 1997 [cited by applicant]
US 5656739A · Cubicciotti · 1997 [cited by applicant]
US 5670633A · Cook et al. · 1997 [cited by applicant]
US 5681943A · Letsinger et al. · 1997 [cited by applicant]
US 5695934A · Brenner · 1997 [cited by applicant]
US 5696251A · Arnold, Jr. et al. · 1997 [cited by applicant]
US 5708153A · Dower et al. · 1998 [cited by applicant]
US 5723289A · Eaton et al. · 1998 [cited by applicant]
US 5723598A · Lerner et al. · 1998 [cited by applicant]
US 5763175A · Brenner · 1998 [cited by applicant]
US 5770358A · Dower et al. · 1998 [cited by applicant]
US 5770367A · Southern et al. · 1998 [cited by applicant]
US 5770455A · Cargill et al. · 1998 [cited by applicant]
US 5780231A · Brenner · 1998 [cited by applicant]
US 5780613A · Letsinger et al. · 1998 [cited by applicant]
US 5789162A · Dower et al. · 1998 [cited by applicant]
US 5807683A · Brenner · 1998 [cited by applicant]
US 5840485A · Lebl et al. · 1998 [cited by applicant]
US 5846719A · Brenner et al. · 1998 [cited by applicant]
US 5846839A · Gallop et al. · 1998 [cited by applicant]
US 5863722A · Brenner · 1999 [cited by applicant]
US 5888737A · DuBridge et al. · 1999 [cited by applicant]
US 5942609A · Hunkapiller et al. · 1999 [cited by applicant]
US 5958691A · Pieken et al. · 1999 [cited by applicant]
US 5962228A · Brenner · 1999 [cited by applicant]
US 6013445A · Albrecht et al. · 2000 [cited by applicant]
US 6027890A · Ness et al. · 2000 [cited by applicant]
US 6060596A · Lerner et al. · 2000 [cited by applicant]
US 6087112A · Dale · 2000 [cited by applicant]
US 6090912A · Lebl et al. · 2000 [cited by applicant]
US 6117976A · Neri et al. · 2000 [cited by applicant]
US 6140489A · Brenner · 2000 [cited by applicant]
US 6140493A · Dower et al. · 2000 [cited by applicant]
US 6143497A · Dower et al. · 2000 [cited by applicant]
US 6150516A · Brenner et al. · 2000 [cited by applicant]
US 6165717A · Dower et al. · 2000 [cited by applicant]
US 6172214B1 · Brenner · 2001 [cited by applicant]
US 6172218B1 · Brenner · 2001 [cited by applicant]
US 6214553B1 · Szostak et al. · 2001 [cited by applicant]
US 6218111B1 · Southern et al. · 2001 [cited by applicant]
US 6235475B1 · Brenner et al. · 2001 [cited by applicant]
US 6281344B1 · Szostak et al. · 2001 [cited by applicant]
US 6329177B1 · Havlina · 2001 [cited by applicant]
US 6352828B1 · Brenner · 2002 [cited by applicant]
US 6368874B1 · Gallop et al. · 2002 [cited by applicant]
US 6406848B1 · Bridgham et al. · 2002 [cited by applicant]
US 6416949B1 · Dower et al. · 2002 [cited by applicant]
US 6479262B1 · Delagrave · 2002 [cited by applicant]
US 6503759B1 · Still et al. · 2003 [cited by applicant]
US 6537776B1 · Short · 2003 [cited by applicant]
US 6537803B1 · Amara et al. · 2003 [cited by applicant]
US 6576426B2 · Southern et al. · 2003 [cited by applicant]
US 6607878B2 · Sorge · 2003 [cited by applicant]
US 6627748B1 · Ju et al. · 2003 [cited by applicant]
US 6654505B2 · Bridgham et al. · 2003 [cited by applicant]
US 6706481B2 · Rajendran et al. · 2004 [cited by applicant]
US 6806052B2 · Bridgham et al. · 2004 [cited by applicant]
US 6831994B2 · Bridgham et al. · 2004 [cited by applicant]
US 6844324B1 · Zhang et al. · 2005 [cited by applicant]
US 6846655B1 · Wagner et al. · 2005 [cited by applicant]
US 6867290B2 · Goldsborough · 2005 [cited by applicant]
US 6875736B2 · Rana · 2005 [cited by applicant]
US 6936467B2 · Kmiec et al. · 2005 [cited by applicant]
US 6936477B2 · Still et al. · 2005 [cited by applicant]
US 6994963B1 · Murphy et al. · 2006 [cited by applicant]
US 7033753B1 · Kool · 2006 [cited by applicant]
US RE39545E · Cargill · 2007 [cited by applicant]
US RE39571E · Cargill · 2007 [cited by applicant]
US RE39606E · Cargill · 2007 [cited by applicant]
US 7217522B2 · Brenner · 2007 [cited by applicant]
US RE39793E · Brenner · 2007 [cited by applicant]
US 7282370B2 · Bridgham et al. · 2007 [cited by applicant]
US 7365179B2 · Brenner · 2008 [cited by applicant]
US 7393665B2 · Brenner · 2008 [cited by applicant]
US 7407757B2 · Brenner · 2008 [cited by applicant]
US 7413536B1 · Dower et al. · 2008 [cited by applicant]
US 7413854B2 · Pedersen et al. · 2008 [cited by applicant]
US 7442160B2 · Liu et al. · 2008 [cited by applicant]
US 7479472B1 · Harbury et al. · 2009 [cited by applicant]
US 7491494B2 · Liu et al. · 2009 [cited by applicant]
US 7537897B2 · Brenner et al. · 2009 [cited by applicant]
US 7557068B2 · Liu et al. · 2009 [cited by applicant]
US 7704925B2 · Gouliaev et al. · 2010 [cited by applicant]
US 7727713B2 · Pedersen et al. · 2010 [cited by applicant]
US 7749699B2 · Kool · 2010 [cited by applicant]
US 7771935B2 · Liu et al. · 2010 [cited by applicant]
US 7915201B2 · Franch et al. · 2011 [cited by applicant]
US 7935658B2 · Morgan et al. · 2011 [cited by applicant]
US 7972992B2 · Morgan et al. · 2011 [cited by applicant]
US 7972994B2 · Morgan et al. · 2011 [cited by applicant]
US 7989395B2 · Morgan et al. · 2011 [cited by applicant]
US 7998673B2 · French et al. · 2011 [cited by applicant]
US RE43097E · Albrecht et al. · 2012 [cited by applicant]
US 8148068B2 · Brenner · 2012 [cited by applicant]
US 8206901B2 · Freskgard et al. · 2012 [cited by applicant]
US 8361713B2 · Bridgham et al. · 2013 [cited by applicant]
US 8722583B2 · Gouliaev et al. · 2014 [cited by applicant]
US 20010031475A1 · Gallop et al. · 2001 [cited by applicant]
US 20020034732A1 · Capon et al. · 2002 [cited by applicant]
US 20020072887A1 · Szalma et al. · 2002 [cited by applicant]
US 20030049616A1 · Brenner et al. · 2003 [cited by applicant]
US 20030059826A1 · Janda et al. · 2003 [cited by applicant]
US 20030119051A1 · Wiessler et al. · 2003 [cited by applicant]
US 20030143561A1 · Pedersen et al. · 2003 [cited by applicant]
US 20030187240A1 · Cook et al. · 2003 [cited by applicant]
US 20030215846A1 · Watt et al. · 2003 [cited by applicant]
US 20040014090A1 · Neri et al. · 2004 [cited by applicant]
US 20040049008A1 · Pedersen et al. · 2004 [cited by applicant]
US 20040083427A1 · Wada · 2004 [cited by applicant]
US 20040259102A1 · Kool · 2004 [cited by applicant]
US 20050059049A1 · Moen et al. · 2005 [cited by applicant]
US 20050100968A1 · Gallop et al. · 2005 [cited by applicant]
US 20050153321A1 · Saba · 2005 [cited by applicant]
US 20050158765A1 · Morgan et al. · 2005 [cited by applicant]
US 20050170376A1 · Liu · 2005 [cited by examiner]
US 20050176948A1 · Gouliaev et al. · 2005 [cited by applicant]
US 20050221316A1 · Pedersen et al. · 2005 [cited by applicant]
US 20050221318A1 · Gouliaev et al. · 2005 [cited by applicant]
US 20050227281A1 · Liu et al. · 2005 [cited by applicant]
US 20050247001A1 · Gouliaev et al. · 2005 [cited by applicant]
US 20050255491A1 · Lee et al. · 2005 [cited by applicant]
US 20060099589A1 · Pedersen et al. · 2006 [cited by applicant]
US 20060099592A1 · Freskgard et al. · 2006 [cited by applicant]
US 20060099626A1 · Harbury et al. · 2006 [cited by applicant]
US 20060115829A1 · Mao et al. · 2006 [cited by applicant]
US 20060121470A1 · Pedersen · 2006 [cited by applicant]
US 20060154246A1 · Neri et al. · 2006 [cited by applicant]
US 20060160125A1 · Kool · 2006 [cited by applicant]
US 20060166197A1 · Gouliaev et al. · 2006 [cited by applicant]
US 20060177833A1 · Brenner · 2006 [cited by applicant]
US 20060193869A1 · Barrat et al. · 2006 [cited by applicant]
US 20060199192A1 · Kool et al. · 2006 [cited by applicant]
US 20060211030A1 · Brenner · 2006 [cited by applicant]
US 20060234231A1 · Freskgard et al. · 2006 [cited by applicant]
US 20060246450A1 · Franch et al. · 2006 [cited by applicant]
US 20060269920A1 · Freskgard et al. · 2006 [cited by applicant]
US 20060292603A1 · Gouliaev et al. · 2006 [cited by applicant]
US 20070022460A1 · Kim et al. · 2007 [cited by applicant]
US 20070026397A1 · Freskgard et al. · 2007 [cited by applicant]
US 20070042401A1 · Morgan et al. · 2007 [cited by applicant]
US 20070213519A1 · Gouliaev et al. · 2007 [cited by applicant]
US 20070224607A1 · Morgan et al. · 2007 [cited by applicant]
US 20080050731A1 · Agnew et al. · 2008 [cited by applicant]
US 20080193983A1 · Gouliaev et al. · 2008 [cited by applicant]
US 20080220982A1 · Vu · 2008 [cited by applicant]
US 20080305957A1 · Thisted et al. · 2008 [cited by applicant]
US 20080318802A1 · Brenner · 2008 [cited by applicant]
US 20090005256A1 · Bittker et al. · 2009 [cited by applicant]
US 20090011957A1 · Gouliaev et al. · 2009 [cited by applicant]
US 20090035824A1 · Liu et al. · 2009 [cited by applicant]
US 20090062147A1 · Morgan et al. · 2009 [cited by applicant]
US 20090143232A1 · Pedersen et al. · 2009 [cited by applicant]
US 20090143244A1 · Bridgham et al. · 2009 [cited by applicant]
US 20090239211A1 · Freskgard et al. · 2009 [cited by applicant]
US 20090239768A1 · Hansen et al. · 2009 [cited by applicant]
US 20090264300A1 · Franch et al. · 2009 [cited by applicant]
US 20100016177A1 · Pedersen et al. · 2010 [cited by applicant]
US 20100055745A1 · Kaufman · 2010 [cited by applicant]
US 20100094036A1 · Hirata et al. · 2010 [cited by applicant]
US 20100159526A1 · Jendrisak et al. · 2010 [cited by applicant]
US 20100184611A1 · Neri et al. · 2010 [cited by applicant]
US 20100184661A1 · Luo et al. · 2010 [cited by applicant]
US 20110003290A1 · Gale et al. · 2011 [cited by applicant]
US 20110104785A1 · Vaidyanathan et al. · 2011 [cited by applicant]
US 20110136697A1 · Morgan et al. · 2011 [cited by applicant]
US 20110183863A1 · Wagner et al. · 2011 [cited by applicant]
US 20110217738A1 · Jacobson · 2011 [cited by applicant]
US 20110251089A1 · Morgan et al. · 2011 [cited by applicant]
US 20110262898A1 · Dong et al. · 2011 [cited by applicant]
US 20110319278A1 · Neri et al. · 2011 [cited by applicant]
US 20120004137A1 · Wagner et al. · 2012 [cited by applicant]
US 20120053091A1 · Wagner · 2012 [cited by applicant]
US 20120071329A1 · Morgan et al. · 2012 [cited by applicant]
US 20120107840A1 · Wagner et al. · 2012 [cited by applicant]
US 20120245040A1 · Morgan et al. · 2012 [cited by applicant]
US 20130046084A1 · Brown et al. · 2013 [cited by applicant]
US 20130102545A1 · Gao et al. · 2013 [cited by applicant]
US 20130237459A1 · Rasmussen · 2013 [cited by applicant]
US 20130281324A1 · Gouliaev et al. · 2013 [cited by applicant]
US 20140315762A1 · Keefe et al. · 2014 [cited by applicant]
CN 1898257A · 2007 [cited by applicant]
DE 19646372C1 · 1997 [cited by applicant]
DE 19642751A1 · 1998 [cited by applicant]
EP 0928290B1 · 2005 [cited by applicant]
EP 1533385A1 · 2005 [cited by applicant]
EP 1423400B1 · 2006 [cited by applicant]
EP 1905829A2 · 2008 [cited by applicant]
EP 1828381B1 · 2009 [cited by applicant]
EP 2175019A2 · 2010 [cited by applicant]
EP 2186897A1 · 2010 [cited by applicant]
EP 2236606A2 · 2010 [cited by applicant]
EP 1957644B1 · 2010 [cited by applicant]
EP 2258870A2 · 2010 [cited by applicant]
EP 2305808A1 · 2011 [cited by applicant]
EP 2311786A2 · 2011 [cited by applicant]
EP 1558744B1 · 2011 [cited by applicant]
EP 2336315A2 · 2011 [cited by applicant]
EP 2338990A2 · 2011 [cited by applicant]
EP 2341140A1 · 2011 [cited by applicant]
EP 2348124A2 · 2011 [cited by applicant]
EP 2348125A2 · 2011 [cited by applicant]
EP 2216338B1 · 2013 [cited by applicant]
EP 2272856B1 · 2015 [cited by applicant]
EP 3351631A2 · 2018 [cited by applicant]
EP 3211126B1 · 2020 [cited by applicant]
GB 93158475 · 1993 [cited by applicant]
JP 5292967A · 1993 [cited by applicant]
JP 8000268A · 1996 [cited by applicant]
JP 2002315577A · 2002 [cited by applicant]
JP 2007529994A · 2007 [cited by applicant]
WO WO9222875A1 · 1992 [cited by applicant]
WO WO9306121A1 · 1993 [cited by applicant]
WO WO9320242A1 · 1993 [cited by applicant]
WO WO9408051A1 · 1994 [cited by applicant]
WO WO9504160A1 · 1995 [cited by applicant]
WO WO9506293A1 · 1995 [cited by applicant]
WO WO9512608A1 · 1995 [cited by applicant]
WO WO9635699A1 · 1996 [cited by applicant]
WO WO9638726A1 · 1996 [cited by applicant]
WO WO9732999A1 · 1997 [cited by applicant]
WO WO9804575A2 · 1998 [cited by applicant]
WO WO9831700A1 · 1998 [cited by applicant]
WO WO9910485A1 · 1999 [cited by applicant]
WO WO9918240A2 · 1999 [cited by applicant]
WO WO0020639A1 · 2000 [cited by applicant]
WO WO0023458A1 · 2000 [cited by applicant]
WO WO0032823A1 · 2000 [cited by applicant]
WO WO0061775A1 · 2000 [cited by applicant]
WO WO0116352A1 · 2001 [cited by applicant]
WO WO0240664A1 · 2002 [cited by applicant]
WO WO02074929A2 · 2002 [cited by applicant]
WO WO02102820A1 · 2002 [cited by applicant]
WO WO02103008A2 · 2002 [cited by applicant]
WO WO03078050A2 · 2003 [cited by applicant]
WO WO03078445A2 · 2003 [cited by applicant]
WO WO03078446A2 · 2003 [cited by applicant]
WO WO03078625A2 · 2003 [cited by applicant]
WO WO03078626A2 · 2003 [cited by applicant]
WO WO03078627A2 · 2003 [cited by applicant]
WO WO2004001042A2 · 2003 [cited by applicant]
WO WO2004009814A1 · 2004 [cited by applicant]
WO WO2004013070A2 · 2004 [cited by applicant]
WO WO2004016767A2 · 2004 [cited by applicant]
WO WO2004024929A2 · 2004 [cited by applicant]
WO WO2004039825A2 · 2004 [cited by applicant]
WO WO2004056994A2 · 2004 [cited by applicant]
WO WO2004074429A2 · 2004 [cited by applicant]
WO WO2004074501A2 · 2004 [cited by applicant]
WO WO2004083427A2 · 2004 [cited by applicant]
WO WO2005008240A2 · 2005 [cited by applicant]
WO WO2005026387A1 · 2005 [cited by applicant]
WO WO2005058479A2 · 2005 [cited by applicant]
WO WO2005078122A2 · 2005 [cited by applicant]
WO WO2005090566A2 · 2005 [cited by applicant]
WO WO2006048025A1 · 2006 [cited by applicant]
WO WO2006053571A2 · 2006 [cited by applicant]
WO WO2006079061A2 · 2006 [cited by applicant]
WO WO2006135786A2 · 2006 [cited by applicant]
WO WO2007041201A2 · 2007 [cited by applicant]
WO WO2007053358A2 · 2007 [cited by applicant]
WO WO2007062664A2 · 2007 [cited by applicant]
WO WO2009066447A1 · 2009 [cited by applicant]
WO WO2009077173A2 · 2009 [cited by applicant]
WO WO2009152824A1 · 2009 [cited by applicant]
WO WO2010086602A1 · 2010 [cited by applicant]
WO WO2010094027A1 · 2010 [cited by applicant]
WO WO2010094036A1 · 2010 [cited by applicant]
WO WO2010094040A1 · 2010 [cited by applicant]
WO WO2011005762A1 · 2011 [cited by applicant]
WO WO2011100058A1 · 2011 [cited by applicant]
WO WO2011120042A1 · 2011 [cited by applicant]
WO WO2011127933A1 · 2011 [cited by applicant]
WO WO2012125733A2 · 2012 [cited by applicant]
WO WO2013036810A1 · 2013 [cited by applicant]
WO WO2014012010A1 · 2014 [cited by applicant]
WO WO2015091207A1 · 2015 [cited by applicant]
Nitin et al. (Nucleic Acids Research, 2004, vol. 32, No. 6, e58) (Year: 2004). [cited by examiner]
Ueno et al. (Int. J. Biol. Sci., 2007, 3:365-374) (Year: 2007). [cited by examiner]
Takahashi et al. (Nucleic Acid and Peptide Aptamers: Methods and Protocols, 2009, pp. 293-314, Humana Press) (Year: 2009). [cited by examiner]
Baji et al. (J. Org. Chem., 2002, 67, 5352-5358) (Year: 2002). [cited by examiner]
Office Action for Brazilian Patent Application No. PI1008429-0, mailed Nov. 24, 2020 (6 pages). [cited by applicant]
Office Action for Canadian Patent Application No. 2,752,543, mailed Oct. 16, 2020 (4 pages). [cited by applicant]
Office Action for Chinese Application No. 201711269685X, dated Feb. 26, 2021 (7 pages). [cited by applicant]
U.S. Appl. No. 61/152,508. [cited by applicant]
Bain et al., “Regioselective ligation of oligoribonucleotides using DNA splints,” Nucleic Acids Res. 20(16):4372 (1992). [cited by applicant]
Barrio et al., “Synthesis of Modified Nucleoside 3′-5′-Bisphosphates and Their Incorporation into Oligoribonucleotides with T4 RNA Ligase,” Biochemistry. 17(11):2077-2081 (1978) (5 pages). [cited by applicant]
Bullard et al., “Direct comparison of nick-joining activity of the nucleic acid ligases from bacteriophage T4, ” Biochem J. 398(1):135-144 (2006) (10 pages). [cited by applicant]
Communication of a Notice of Opposition to European Patent No. 3211126, dated Jul. 27, 2021 (88 pages). [cited by applicant]
England et al., “Enzymatic Oligoribonucleotide Synthesis with T4 RNA Ligase,” Biochemistry. 17(11):2069-76 (1978) (8 pages). [cited by applicant]
Iuodka et al., “Study of the substrate specificity of T4 RNA ligase: Interaction of the enzyme with ATP analogs modified through the ribose residue and with affinity sorbents,” Biokhimiia. 60(3):478-484 (1995) (7 pages). [cited by applicant]
Ma et al., “PEG 400, a Hydrophilic Molecular Probe for Measuring Intestinal Permeability,” Gastroenterology. 98(1):39-46 (1990) (8 pages). [cited by applicant]
Nichols et al., “RNA Ligases,” Curr Protoc Mol Biol. 3(15):1-4 (2008) (4 pages). [cited by applicant]
Notice of Reasons for Rejection and English Translation for Japanese Patent Application No. 2019-082384, dated May 31, 2021 (4 pages). [cited by applicant]
Stark et al., “An RNA ligase-mediated method for efficient creation of large, synthetic RNAs,” RNA. 12(11):2014-2019 (2006) (6 pages). [cited by applicant]
Pre-Grant Opposition Notice for Indian Patent Application No. 6461/CHENP/2011, mailed Feb. 22, 2022 (1 page). [cited by applicant]
First Examination Report for Indian Patent Application No. 6461/CHENP/2011, mailed Oct. 13, 2017 (6 pages). [cited by applicant]
“Polyethylene Glycols,” FNP. 38 (1998) (11 pages). [cited by applicant]
“Versatile New Reagents—Pyrene-Du and Perylene-Du,” Glen Research Report of Products for RNA and DNA Oligonucleotide Synthesis, <https://www.glenresearch.com/reports/gr19-28.html>, dated Aug. 21, 2008, retrieved Apr. 12… [cited by applicant]
Form 1 Application for Grant of Patent, Form 2 Complete Specification, and Form 3 Application for Amendment of the Application for Indian Patent Application No. 6461/CHENP/2011, dated Sep. 8, 2011 (73 pages). [cited by applicant]
Reply to the Examination Report for Indian Patent Application No. 6461/CHENP/2011, dated Apr. 10, 2018 (18 pages). [cited by applicant]
Claim Correspondence Table for European U.S. Appl. No. 10/741,877, filed Feb. 16, 2010, and Indian Patent Application No. 6461/CHENP/2011 (41 pages). [cited by applicant]
Annex A—Overview of Entitlement to Priority for United States U.S. Appl. No. 61/152,508 and International Patent Application No. WO2010/094036 (32 pages). [cited by applicant]
Certified Priority Application for International Application No. PCT/US2010/024314, filed Feb. 16, 2010 (28 pages). [cited by applicant]
U.S. Appl. No. 61/531,820, Keefe et al. [cited by applicant]
U.S. Appl. No. 61/536,929, Keefe et al. [cited by applicant]
“Pharmacology Frontier—Signal, Protein factor, Gene and Modern Pharmacology”, compiled mainly by WEI Erging, Science and Technology Press, p. 314-316 (1999) (4 pages). [cited by applicant]
Abe et al., “Structure analysis of oligonucleotide in organic solvent,” Nucleic Acids Symposium Series. 50:25-6 (2006). [cited by applicant]
Amato, “Speeding up a chemical game of chance,” Science. 257(5068):330-1 (1992). [cited by applicant]
Anonymous, “5-F-DU-CE Phosphoramidite,” Glen Research Report of Products for RNA and DNA Oligonucleotide Synthesis. (2004) (3 pages). [cited by applicant]
Anonymous, “Non-enzymatic ligation of single-stranded and duplex DNA,” Glen Research Report of Products for RNA and DNA Oligonucleotide Synthesis. 10 (1997). (1 page). [cited by applicant]
Anonymous, “PDC-CE Phosphoramidite,” Glen Research Report of Products for RNA and DNA Oligonucleotide Synthesis. (2004) (3 pages). [cited by applicant]
Anonymous, “PDU-CE Phosphoramidite,” Glen Research Report of Products for RNA and DNA Oligonucleotide Synthesis. (2004) (3 pages). [cited by applicant]
Anonymous, “Versatile New Reagents: Pyrene-dU and Perylene-dU,” Glen Research Report of Products for RNA and DNA Oligonucleotide Synthesis. (2008) (2 pages). [cited by applicant]
Asanuma et al., “Photocontrol of DNA duplex formation by using azobenzene-bearing oligonucleotides,” Chembiochem. 2(1):39-44 (2001). [cited by applicant]
Asanuma et al., “Synthesis of azobenzene-tethered DNA for reversible photo-regulation of DNA functions: hybridization and transcription,” Protocol. 2(1):203-212 (2007) (11 pages). [cited by applicant]
Balanov et al., “Development of DNA-encoded library containing 10 [cited by applicant]
Bartel et al., “Isolation of new ribozymes from a large pool of random sequences,” Science. 261(5127):1411-8 (1993). [cited by applicant]
Beaucage et al., “The functionalization of oligonucleotides via phosphoramidite derivatives,” Tetrahedron 49(10):1925-63 (1993). [cited by applicant]
Berezovski et al., “Non-SELEX: selection of aptamers without intermediate amplification of candidate oligonucleotides,” Nat Protoc. 1(3):1359-69 (2006). [cited by applicant]
Berger et al., “Chemistry on nucleic acid templates,” Chem Biodivers. 7(10):2581-615 (2010). [cited by applicant]
Blondal et al., “Isolation and characterization of a thermostable RNA ligase 1 from a Thermus scotoductus bacteriophage TS2126 with good single-stranded DNA ligation properties,” Nucleic Acids Res. 33(1):135-42 (2005). [cited by applicant]
Bonora et al., “Synthesis and characterization of high-molecular mass polyethylene glycol-conjugated oligonucleotides,” Bioconjug Chem. 8(6):793-7 (1997). [cited by applicant]
Brenner et al., “Encoded combinatorial chemistry,” Proc Natl Acad Sci U.S.A. 89(12):5381-3 (1992). [cited by applicant]
Brenner et al., “Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays,” Nat Biotechnol. 18(6): 630-4 (2000). [cited by applicant]
Brenner et al., “In vitro cloning of complex mixtures of DNA on microbeads: physical separation of differentially expressed cDNAs,” Proc Natl Acad Sci U.S.A. 97(4): 1665-70 (2000). [cited by applicant]
Bruick et al., “Template-directed ligation of peptides to oligonucleotides,” Chem Biol. 3(1):49-56 (1996). [cited by applicant]
Chapter 5: Crosslinking and Photoactivatable Reagents. [cited by applicant]
Chen et al., “Template-directed chemical ligation to obtain 3′-3′ and 5′-5′ phosphodiester DNA linkages,” Sci Rep. 4:4595 (2014) (6 pages). [cited by applicant]
Cherepanov et al., “Scanning mutagenesis using T4 DNA ligase and short degenerate DNA oligonucleotides containing tri-nucleotide mismatches,” J Biochem. 132(1):143-7 (2002). [cited by applicant]
Chiu et al., “Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells,” Chem Biol. 11(8):1165-75 (2004). [cited by applicant]
Clark et al., “Design, synthesis and selection of DNA-encoded small-molecule libraries,” Nat Chem Biol. 5(9):647-54 (2009). [cited by applicant]
Clark et al., Supplementary Methods for “Design, synthesis and selection of DNA-encoded small-molecule libraries,” Nat Chem Biol. 5(9):647-54 (2009) (57 pages). [cited by applicant]
Communication of a Notice of Opposition for European Patent Application No. 13816635.0, dated Jan. 10, 2019 (37 Pages). [cited by applicant]
Communication of a Notice of Opposition to European Patent No. 2396459, dated Feb. 9, 2018 (83 pages). [cited by applicant]
Communication of Opposition to European Patent No. 2,748,357, dated Jan. 4, 2019 (42 Pages). [cited by applicant]
Communication pursuant to Article 94(3) EPC for European Patent Application No. 10741877.4, dated Mar. 24, 2016 (6 pages). [cited by applicant]
Communication pursuant to Rule 114(2) EPC for European Patent Application No. 10741877.4, dated Oct. 7, 2016 (29 pages). [cited by applicant]
Cui, “Have the primary structures of biomacromolecules been selected in a Darwinian fashion to adapt to the surrounding environments of our planet?,” IUBMB Life 61(8):860-3 (2009). [cited by applicant]
Cummins et al., “Characterization of fully 2′-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity,” Nucleic Acids Res. 23(11):2019-24 (1995). [cited by applicant]
Didenko et al., “Substantial Background Reduction in Ligase-based Apoptosis Detection Using Newly Designed Hairpin Oligoprobes,” available in PMC Jun. 18, 2007, published in final edited form as: Biotechniques. 27:1130-… [cited by applicant]
Dimitri et al., “Transcription elongation past O6-methylguanine by human RNA polymerase II and bacteriophage T7 RNA polymerase,” Nucleic Acids Res. 36(20):6459-71 (2008). [cited by applicant]
Ding, Jinfeng et al., “Gene analysis and Bio-chip technology,” Wuhan: Hubei Science and Technology Press, pp. 108-109 (2004) (8 pages). [cited by applicant]
Efimov et al., “Cross-linked nucleic acids: formation, structure, and biological function,” Russ J Bioorg Chem. 36(1):49-72 (2010). [cited by applicant]
Ekland et al., “Structurally complex and highly active RNA ligases derived from random RNA sequences,” Science. 269(5222):364-70 (1995). [cited by applicant]
El-Sagheer et al., “Click nucleic acid ligation: applications in biology and nanotechnology,” Acc Chem Res. 45(8):1258-67 (2012). [cited by applicant]
El-Sagheer et al., “Efficient RNA synthesis by in vitro transcription of a triazole-modified DNA template,” Chem Commun (Camb). 47(44):12057-8 (2011). [cited by applicant]
Engelhart et al., “Nonenzymatic ligation of DNA with a reversible step and a final linkage that can be used in PCR,” Chembiochem. 13(8):1121-4 (2012). [cited by applicant]
English Translation of Office Action for Israeli Application No. 214399, dated Mar. 20, 2018 (2 pages). [cited by applicant]
English Translation of Third Party Submission of Information for Japanese Application No. 2017-161747, Dated May 14, 2018 (198 pages). [cited by applicant]
European Search Report for European Patent Application No. 19208965.4, dated Mar. 30, 2020 (10 pages). [cited by applicant]
Examination Report for Indian Patent Application No. 6461/CHENP/2011, dated Oct. 13, 2017 (6 pages). [cited by applicant]
Examination Report for Singaporean Application No. 2014011381, dated Apr. 3, 2020 (6 pages). [cited by applicant]
Extended European Search Report for European Patent Application No. 10741870.9, dated Jul. 10, 2012 (12 pages). [cited by applicant]
Extended European Search Report for European Patent Application No. 10741877.4, dated Jun. 27, 2012 (8 pages). [cited by applicant]
Extended European Search Report for European Patent Application No. 17163865.3, dated May 17, 2017 (9 pages). [cited by applicant]
Ferris et al., “N-cyanoimidazole and diimidazole imine: water-soluble condensing agents for the formation of the phosphodiester bond,” Nucleosides Nucleotides. 8(3):407-14 (1989). [cited by applicant]
File History for European Patent Application No. 03757752.5 (1,559 pages). [cited by applicant]
File History for U.S. Appl. No. 10/525,817 mailed May 1, 2011 (735 pages). [cited by applicant]
Fujimoto et al., “A light-controlled reversible DNA photoligation via carbazole-tethered 5-carboxyvinyluracil,” Org Lett. 10(3):397-400 (2008). [cited by applicant]
Gartner et al., “The generality of DNA-templated synthesis as a basis for evolving non-natural small molecules,” J Am Chem Soc. 123(28):6961-3 (2001). [cited by applicant]
Glen Research Information and MSDS for 5′-Dimethoxytrityl-5-[N-(trifluoroacetylaminohexyl)-3-acrylimido]-2′-deoxyUridine,3′-[(2-cyanoethyl)-(N, N-diisopropyl)]-phosphoramidite (Catalogue No. 10-1039-xx from Apr. 14, 200… [cited by applicant]
Glen Research Information and MSDS for 5-F-dU-CE Phosphoramidite (Catalogue No. 10-1092-xx from Oct. 28, 2004 and Apr. 28, 2005), available at: https://web.archive.org/web/20050428232151/http://www.glenresearch.com/Prod… [cited by applicant]
Glen Research Information and MSDS for pdC-CE Phosphoramidite (Catalogue No. 10-1014-xx from Sep. 1, 2004 and Mar. 8, 2005), available at: https://web.archive.org/web/20050308232245/http://www.glenresearch.com:80/Produc… [cited by applicant]
Glen Research Information and MSDS for pdU-CE Phosphoramidite (Catalogue No. 10-1054-xx from Oct. 28, 2004 and Mar. 8, 2005), available at: https://web.archive.org/web/20050308232237/http://www.glenresearch.com/ProductF… [cited by applicant]
Glen Research Information for Pyrene-dU-CE Phosphoramidite (Catalogue No. 10-1590-xx from Aug. 21, 2008 and Dec. 2, 2008), available at: https://web.archive.org/web/20081202060550/http://www.glenresearch.com/Catalog/str… [cited by applicant]
Goodwin et al., “Template-directed synthesis: use of a reversible reaction,” J Am Chem Soc. 114(23):9197-8 (1992). [cited by applicant]
Géron-Landre et al., “Sequence-specific fluorescent labeling of double-stranded DNA observed at the single molecule level,” Nucleic Acids Res. 31(20):e125 (2003) (8 pages). [cited by applicant]
Halpin et al., “DNA display I. Sequence-encoded routing of DNA populations,” PLoS Biol. 2(7):E173 (2004) (7 pages). [cited by applicant]
Halpin et al., “DNA display II. Genetic manipulation of combinatorial chemistry libraries for small-molecule evolution,” PLoS Biol. 2(7):E174 (2004) (9 pages). [cited by applicant]
Harada et al., “In vitro selection of optimal DNA substrates for T4 RNA ligase,” Proc Natl Acad Sci U.S.A. 90(4):1576-9 (1993). [cited by applicant]
Herrlein et al., “A covalent lock for self-assembled oligonucleotide conjugates,” J Am Chem Soc. 117(40):10151-2 (1995). [cited by applicant]
Hoepfner et al., “Amplified primer extension assay for psoralen photoproducts provides a sensitive assay for a (CG)6TA(CG)2(TG)8 Z-DNA torsionally tuned probe: preferential psoralen photobinding to one strand of a B-Z j… [cited by applicant]
Integrated DNA Technologies, Inc. for “Int Spacer 9” (iSp9—Product No. 1391 from Oct. 16, 2006 and Nov. 9, 2006) available at <https://web.archive.org/web/20071109184957/http://www.idtdna.com:80/Catalog/Modifications/RN… [cited by applicant]
Integrated DNA Technologies, Inc. for “Int Uni-Link™ Amino Modifier” (iUniAmM—Product No. 1440 from Oct. 16, 2006 and Nov. 15, 2006) available at <https://web.archive.org/web/20061115041630/http://www.idtdna.com:80/Cata… [cited by applicant]
Interlocutory Decision in Opposition Proceedings (Art. 101(3)(a) and 106(2) EPC) for European Application No. 13816635.0, dated Apr. 7, 2020 (144 pages). [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2010/024296, mailed Jun. 10, 2010 (11 pages). [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2010/024314, mailed May 7, 2010 (6 pages). [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2012/054228, mailed Jan. 7, 2013 (9 pages). [cited by applicant]
Ito et al., “Modification of lipase with various synthetic polymers and their catalytic activities in organic solvent,” Biotechnol Prog. 10(4):398-402 (1994). [cited by applicant]
Janda, “Tagged versus untagged libraries: methods for the generation and screening of combinatorial chemical libraries,” Proc Natl Acad Sci U.S.A. 91(23):10779-85 (1994). [cited by applicant]
Jarosch et al., “In vitro selection using a dual RNA library that allows primerless selection,” Nucleic Acids Res. 34(12):e86 (2006) (9 pages). [cited by applicant]
Jenne et al., “A novel ribozyme with ester transferase activity,” Chem Biol. 5(1):23-34 (1998). [cited by applicant]
Jinfeng et al., “Gene Analysis and Biochip Technique,” compiled mainly by DING, Hubei Science and Technology Press, p. 108-109 (2004) (3 pages). [cited by applicant]
Jäschke et al., “Synthesis and properties of oligodeoxyribonucleotide-polyethylene glycol conjugates,” Nucleic Acids Res. 22(22):4810-7 (1994). [cited by applicant]
Jäschke, Chapter 18: Oligonucleotide-Poly(ethylene glycol) Conjugates: Synthesis, Properties, and Applications. [cited by applicant]
Kanaya et al., “Template-Directed Polymerization of Oligoadenylates Using Cyanogen Bromide,” Biochemistry. 25(23):7423-30 (1986). [cited by applicant]
Kempe et al., “Chemical and enzymatic biotin-labeling of oligodeoxyribonucleotides,” Nucleic Acids Res. 13(1):45-57 (1985). [cited by applicant]
Khakshoor et al., “Chemistry of nucleic acids: impacts in multiple fields,” Chem Commun. 47(25):7018-24 (2011). [cited by applicant]